Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36421 | Immuno-Oncology Screening Library | ||
The Immuno-Oncology Screening Library consists of 2 plates and contains more than 90 cancer and immunology-associated compounds in a 96-well Matrix tube rack format as 10 mM stock solutions in DMSO. This library includes a variety of immuno-oncology target modulators, including but not limited to, adenosine, CCR, CXCR, and TLR agonists and antagonists, BTK, PI3K, VEGFR, and BRAF inhibitors, PD-1/PDL-1 interaction inhibitors, and HDAC inhibitors. Please review the product insert for a full list ... | |||
T10777 |
CG347B
|
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
CG347B 是一种选择性HDAC6抑制剂。 | |||
T0964 |
Floxuridine
氟尿苷,5-Fluorouracil 2'-deoxyriboside,FUDR,Deoxyfluorouridine,NSC 27640 |
Apoptosis; Nucleoside Antimetabolite/Analog; Others; DNA/RNA Synthesis; Antibacterial; HSV | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Others |
Floxuridine (FUDR) 是一种嘧啶类似物,也是一种抗肿瘤代谢物。它抑制胸苷酸合成酶,导致 DNA 合成中断和细胞毒性。它是一种可诱导细胞凋亡的金黄色葡萄球菌感染抑制剂 ,具有抗HSV 和CMV 病毒的作用。 | |||
T4314 |
EPZ020411
EPZ020411 2HCl |
Histone Methyltransferase | Chromatin/Epigenetic |
EPZ020411是一种特异性有效的 PRMT6 抑制剂, IC50 为 10 nM,比作用于 PRMT1 和 PRMT8 的选择性高10倍多。 | |||
T9523 |
TGFβRI-IN-3
|
TGF-beta/Smad | Stem Cells |
TGFβRI-IN-3 抑制TGFβR1,IC50为 0.79 nM,是对 MAP4K4 的选择性2000 倍。TGFβRI-IN-3 是一种高选择性的 TGFβR1 抑制剂,在免疫肿瘤中具有潜在的应用。 | |||
T9619 |
I-BET567
|
||
I-BET567 是一种有效、具有口服活性的泛BET 候选抑制剂,对 BRD4 BD1 和 BD2 的pIC50s 分别为 6.9 和 7.2。I-BET567 在肿瘤和炎症的小鼠模型中已被证明有效。 | |||
T21322 |
Mavelertinib
PF 06747775,PFE-X775,PF-06747775,PF-7775,PF 6747775,PF6747775 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mavelertinib (PF-06747775) 是一种可口服且具有选择性和有效性的 EGFR 酪氨酸激酶 (EGFR TKI)抑制剂,对 T790M/L858R 和 T790M/Del 具有抑制作用,可用于研究肿瘤和呼吸系统疾病。 | |||
T27643 |
Izonsteride
LY-320236,LY320236,UNII-A5E8C36F34 |
Reductase | Endocrinology/Hormones; Metabolism |
Izonsteride (LY320236) 是一种选择性强效 5α 还原酶抑制剂,对酶的 I 型和 II 型同工酶具有双重作用。Izonsteride 可用于治疗肿瘤和泌尿生殖系统疾病,可用于研究前列腺癌。 | |||
T50100 |
3-hydroxy-3-phenylpentanamide
|
Others | Others |
3-hydroxy-3-phenylpentanamide 是一种手性化合物,属于β-羟基酰胺类。在神经病学中,它已被证明对缺血性脑损伤和脑出血具有神经保护作用。在精神病学中,它被研究为焦虑、抑郁和成瘾的潜在治疗方法。在肿瘤学中,它已被证明通过诱导细胞凋亡和抑制肿瘤生长而具有抗肿瘤活性。 | |||
T26723 |
AZD8542
AZD-8542,AZD 8542 |
||
AZD8542 is an antagonist of Smoothened (SMO) with potential as an oncology therapeutic. | |||
T31410 |
D-Fluoromethyltyrosine F-18
BAY 86 9596,BAY 869596,BAY 86-9596,J2.566.882K,BAY-86-9596 F-18 |
||
Fluoroethyl-l-tyrosine (18F) or 18F-FET is a neuro-oncology PET tracer. | |||
T74666 |
KTX-497
|
||
KTX-497 是一种 IRAK4降解剂,具有口服活性,DC50值为 3 nM。KTX-497 可用于肿瘤学研究。 | |||
T82920 |
Barzuxetan
CHX-A''-DTPA-NCS |
||
Barzuxetan 用于癌症研究。 | |||
T61336 | Numidargistat dihydrochloride | ||
Numidargistat dihydrochloride (CB-1158) is a highly potent and orally active chemical compound that effectively inhibits arginase. It exhibits IC50 values of 86 nM and 296 nM for recombinant human arginase 1 and 2, respectively. Numidargistat dihydrochloride contributes to immuno-oncology, making it a valuable agent in the field [1]. | |||
T73296 |
iBRD4-BD1
|
||
iBRD4-BD1 是选择性 BRD4溴结构域抑制剂。iBRD4-BD1 对 BRD4溴结构域具有抑制活性,IC50值为 12 nM。iBRD4-BD1 可用于炎症和肿瘤学的研究。 | |||
T70870 |
AC430
|
||
AC430 is a potent and specific small molecule inhibitor of janus kinase 2 (JAK2), which has been implicated as a target for therapy in both oncology and autoimmune disease. AC430 is currently being developed by Ambit. In preclinical studies, AC430 has exhibited potency against JAK2 and V617F mutated JAK2 in cell-based models that is at least equivalent to, and in most cases superior to, competing JAK2 inhibitors. In preclinical oncology and autoimmune models, AC430 is well tolerated and has sign... | |||
T36761 | KRAS inhibitor-10 | ||
KRAS inhibitor-10 (WO2021005165 A1, compound 11) is a potent and selective inhibitor of RAS proteins, with a specific focus on KRAS proteins. This orally active anti-cancer agent demonstrates strong efficacy in cancer research, specifically in pancreatic cancer, breast cancer, multiple myeloma, leukemia, and lung cancer. KRAS inhibitor-10 is classified as a tetrahydroisoquinoline compound. Its inhibitory properties provide valuable insights and potential therapeutic applications in the field of ... | |||
T74667 |
KTX-612
|
||
KTX-612 是一种IRAK4降解剂,具有口服活性,DC50值为 7 nM。KTX-612 可用于肿瘤学研究。 | |||
T69751 |
UK-356202
|
||
UK-356,202 is a potent and selective urokinase-type plasminogen activator (Ki = 37 nM). Urokinase plasminogen activator (uPA, urokinase) is a trypsinlike serine protease and a therapeutical target for many cancer types, including breast, ovarian, and pancreatic cancer. uPA is a valuable oncology target. | |||
T77040 | Iparomlimab | ||
Iparomlimab 是一种 IgG4κ 抗体,抗人 PD-1/CD279/PDCD1,并靶向人单克隆 PSB103 γ4 链,形成二硫键二聚体。适用于肿瘤学研究。 | |||
T79018 |
GSK217
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GSK217为一种针对(BET)第二溴化结构域(BD2)的强效、选择性及高溶解度抑制剂,应用于肿瘤及免疫炎症研究领域。 | |||
T81708 |
Nagrestipen
|
||
Nagrestipen 是一种人巨噬细胞炎症蛋白-1α 变体,也称为 ECI 301,主要用于癌症、肿瘤、转移、放射肿瘤学以及肿瘤转移研究试验,具有显著的抗肿瘤活性。 | |||
T63418 |
GSK040
|
||
GSK040 是一种有效和具有选择性的BETBD2抑制剂,pIC50值为 8.3。GSK040 对 BETBD2的选择性比 BETBD1(pIC50=4.6) 高 5000 倍。GSK040 可用于肿瘤学和免疫学疾病的研究。 | |||
T73390 | I-BET432 | ||
I-BET432 是一种BET 抑制剂。I-BET432 抑制BRD4的 N 端溴化域 (BD1) 和 C 端溴化域 (BD2) 的pIC50值分别为 7.5 和 7.2。I-BET432 可作为多种肿瘤和炎症疾病研究的口服候选分子。 | |||
T80141 |
Crotalicidin
|
||
Crotalicidin为一种具有抗菌和抗肿瘤特性的肽,可抑制革兰氏阴性细菌及肿瘤细胞。该化合物来源于响尾蛇毒液,常用于微生物感染和癌症领域研究。 | |||
T79313 |
BI 7446
|
STING | Immunology/Inflammation |
BI 7446 是一种基于环状二核苷酸 (CDN) 的高效、特异性STING (干扰素基因刺激蛋白) 激动剂。它能激活所有五种STING变体并在体外诱导肿瘤特异性的免疫介导反应,从而消除肿瘤。此化合物适用于免疫肿瘤学领域的研究。 | |||
T37014 | Inupadenant | ||
Inupadenant is an orally active, highly selective A2A receptor antagonist. Inupadenant is not brain-penetrant. Inupadenant has potent anti-tumor activity[1]. [1]. Laurence Buisseret, et al. Phase 1 trial of the adenosine A2Areceptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A2A receptor within the tumor. Journal of Clinical Oncology. Volume 39, Issue 15_suppl. | |||
T82060 |
Interleukin-6 fragment (human)
|
||
Interleukin-6 fragment (human) 是一种多效性细胞因子,由淋巴细胞及非淋巴细胞产生。该分子的编码基因位于人类第7号染色体,长度大约为5 kb。Interleukin-6 fragment (human) 在免疫响应、急性相应、炎症过程、癌症治疗及血液造血方面均有重要的潜在应用。 | |||
T76986 | Tarlatamab | ||
Tarlatamab (AMG-757) 是一种双特异性 T 细胞接合剂 (BiTE) 抗体,靶向 delta 样配体 3 (DLL3)。DLL3 是在小细胞肺癌 (SCLC) 肿瘤中选择性表达的靶标,但在正常组织中表达很少。Tarlatamab 对人和非人灵长类动物 (NHP) 的 DLL3 的KD 分别为 0.64 nM 和 0.50 nM,对CD3的KD 分别为 14.9 nM 和 12 nM。Tarlatamab 是针对 DLL3 的一流 HLE BiTE 免疫肿瘤疗法,具有用于 SCLC 研究的潜力。 |